Nasdaq:US$40.98 (-0.83) | HKEX:HK$71.80 (-5.80) | AIM:£5.92 (+0.14)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn’s Disease Trial for HMPL-004 Delivers Encouraging Results

1 items
a090713